ArticleOncogene2021
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors.
Stefano Di Giulio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it
ArticleOncogene2021
Stefano Di Giulio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.